Canada vs Spain: Reported rate of new cervical cancer cases
Canada
6.23 per 100,000 women
in 2017
Spain
5.54 per 100,000 women
in 2016
Canada rank
32nd
Spain rank
34th
Reported rate of new cervical cancer cases over time
- Canada
- Spain
How they compare
Canada currently reports 6.23 per 100,000 women against 5.54 per 100,000 women in Spain, a difference of 0.69 per 100,000 women.
That makes Canada's figure about 1.1 times Spain's.
The two have swapped places 6 times across 24 shared years of data; in 1993 it was Canada ahead.
Canada ranks 32nd and Spain ranks 34th of 46 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Spain | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.39 per 100,000 women | 6.72 per 100,000 women | 0.6676 per 100,000 women | Canada |
| 2000s | 6.39 per 100,000 women | 6.2 per 100,000 women | 0.1856 per 100,000 women | Canada |
| 2010s | 5.99 per 100,000 women | 5.6 per 100,000 women | 0.3908 per 100,000 women | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Canada or Spain?
- Canada, at 6.23 per 100,000 women against 5.54 per 100,000 women in Spain as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Canada and Spain?
- 0.69 per 100,000 women, with Canada ahead.
- How many years of comparable data are there for Canada and Spain?
- 24 years are reported by both, from 1993 to 2016.
- How do Canada and Spain rank globally for reported rate of new cervical cancer cases?
- Canada ranks 32nd and Spain ranks 34th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.